Pimecrolimus Cream
Product Images NDC 0591-2944

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Pimecrolimus (NDC 0591-2944). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

The Structural Formula Of Pimecrolimus Is (1r,9s,12s,13r,14s,17r,18e,21s,23s,24r,25s,27r)-12-[(1e)-2-{(1r,3r,4s)-4-chloro-3-methoxycyclohexyl}-1-methylvinyl]-17-ethyl-1,14-dihydroxy-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-aza-tricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetraone. The Compound Has The Molecular Formula C43h68cino11 And The Molecular Weight Of 810.47. (Pimecrolimus Cream A209345 1)

The Structural Formula Of Pimecrolimus Is (1r,9s,12s,13r,14s,17r,18e,21s,23s,24r,25s,27r)-12-[(1e)-2-{(1r,3r,4s)-4-chloro-3-methoxycyclohexyl}-1-methylvinyl]-17-ethyl-1,14-dihydroxy-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-aza-tricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetraone. The Compound Has The Molecular Formula C43h68cino11 And The Molecular Weight Of 810.47. (Pimecrolimus Cream A209345 1)
FDA Label Image

Figure 1 Depicts The Time Course Of Improvement In The Percent Body Surface Area Affected As A Result Of Treatment With Pimecrolimus Cream, 1% In 2 To 17 Year Olds. (Pimecrolimus Cream A209345 2)

Figure 1 Depicts The Time Course Of Improvement In The Percent Body Surface Area Affected As A Result Of Treatment With Pimecrolimus Cream, 1% In 2 To 17 Year Olds. (Pimecrolimus Cream A209345 2)
This appears to be a graph depicting the "Body Surface Area Over Time". The Y-axis denotes "% Body Surface Area Affected" with mean and 95% confidence interval values displayed. The X-axis displays the "Time (days)" label with corresponding values marked from 0 to 43. It is not clear what the units are.*
FDA Label Image

Figure 2 Shows The Time Course Of Improvement In Erythema As A Result Of Treatment With Pimecrolimus Cream, 1% In 2 To 17 Year Olds. (Pimecrolimus Cream A209345 3)

Figure 2 Shows The Time Course Of Improvement In Erythema As A Result Of Treatment With Pimecrolimus Cream, 1% In 2 To 17 Year Olds. (Pimecrolimus Cream A209345 3)
FDA Label Image

1 (Pimecrolimus Cream A209345 4)

1 (Pimecrolimus Cream A209345 4)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.